Gland Pharma
Gland Pharma Limited, commonly referred to as Gland Pharma, is a prominent player in the pharmaceutical preparation manufacturing industry, headquartered in India. Established in 1978, the company has grown to become a key supplier of high-quality injectable medicines and sterile pharmaceutical products, serving global markets across North America, Europe, and emerging regions.
Specialising in the development and manufacturing of complex generic formulations, Gland Pharma is recognised for its robust product portfolio and adherence to stringent quality standards. Its core offerings include injectables, biosimilars, and other sterile dosage forms, which are distinguished by their innovation and reliability. With a strong market presence and notable achievements in the pharmaceutical sector, Gland Pharma continues to expand its footprint as a trusted provider of essential medicines worldwide.
-11 vs industry average
Gland Pharma’s score of 29 is lower than 43% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Gland Pharma?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Gland Pharma's reported carbon emissions
Gland Pharma, a pharmaceutical preparation manufacturing company headquartered in India, reported its climate-related data for several years.
For the reporting year 2025 (data submitted in 2026), Gland Pharma's Scope 1 emissions were approximately 13,920,000 kg CO2e, and Scope 2 emissions were about 80,824,000 kg CO2e. The total combined Scope 1 and 2 emissions for this period were approximately 94,744,000 kg CO2e.
In the reporting year 2025 (data submitted in 2026), for FY2024-25, Scope 1 emissions stood at approximately 15,736,000 kg CO2e, with Scope 2 emissions at approximately 81,154,000 kg CO2e. This resulted in combined Scope 1 and 2 emissions of roughly 96,890,000 kg CO2e.
For the reporting year 2024 (data submitted in 2025), Gland Pharma disclosed Scope 1 emissions of approximately 11,929,600 kg CO2e and Scope 2 emissions of approximately 80,669,600 kg CO2e. The combined Scope 1 and 2 emissions for this period amounted to approximately 92,599,200 kg CO2e.
In the reporting year 2023 (data submitted in 2025), Scope 1 emissions were approximately 12,579,300 kg CO2e, and Scope 2 emissions were approximately 78,475,200 kg CO2e. The total for Scope 1 and 2 emissions was approximately 91,054,500 kg CO2e.
Gland Pharma's reporting indicates that Scope 3 emissions data, specifically for purchased goods and services, was not yet available for these reporting years.
The company's climate commitments and reduction targets are not detailed in the provided information. However, Gland Pharma is identified as a current subsidiary, and its performance data is sourced from "Gland Pharma Limited" at cascade level 0.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Gland Pharma’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Gland Pharma yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Gland Pharma
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project